These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16115478)
21. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM; Yao G J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962 [TBL] [Abstract][Full Text] [Related]
22. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869 [TBL] [Abstract][Full Text] [Related]
23. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function. Liu S; Yamauchi H Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451 [TBL] [Abstract][Full Text] [Related]
24. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration. Lavigne MC; Grimsby JL; Eppihimer MJ J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747 [TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049 [TBL] [Abstract][Full Text] [Related]
26. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation. Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109 [TBL] [Abstract][Full Text] [Related]
27. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA; DeLorenzo RJ; Tombes RM Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994 [TBL] [Abstract][Full Text] [Related]
28. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways. Lan T; Wu T; Chen C; Chen X; Hao J; Huang J; Wang L; Huang H Mol Cell Endocrinol; 2014 Mar; 384(1-2):109-16. PubMed ID: 24508662 [TBL] [Abstract][Full Text] [Related]
29. IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Kuemmerle JF; Zhou H; Bowers JG Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G412-9. PubMed ID: 14592948 [TBL] [Abstract][Full Text] [Related]
30. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression. Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640 [TBL] [Abstract][Full Text] [Related]
31. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
32. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Nonaka M; Pawankar R; Tomiyama S; Yagi T Am J Rhinol; 1999; 13(4):267-72. PubMed ID: 10485012 [TBL] [Abstract][Full Text] [Related]
33. Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines. Yoshimura T; Kurita C; Yamazaki F; Shindo J; Morishima I; Machida K; Sumita T; Horiba M; Nagai H Biol Pharm Bull; 1995 Jun; 18(6):876-81. PubMed ID: 7550124 [TBL] [Abstract][Full Text] [Related]
34. Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation. Li F; Yu X; Szynkarski CK; Meng C; Zhou B; Barhoumi R; White RE; Heaps CL; Stallone JN; Han G PLoS One; 2013; 8(6):e64771. PubMed ID: 23840305 [TBL] [Abstract][Full Text] [Related]
35. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Kanai K; Asano K; Hisamitsu T; Suzaki H Eur Respir J; 2004 May; 23(5):671-8. PubMed ID: 15176678 [TBL] [Abstract][Full Text] [Related]
36. Suppression of co-stimulatory molecule expressions on splenic B lymphocytes by a macrolide antibiotic, roxithromycin in vitro. Asano K; Suzuki M; Shimane T; Suzaki H Int Immunopharmacol; 2001 Jul; 1(7):1385-92. PubMed ID: 11460318 [TBL] [Abstract][Full Text] [Related]
37. The macrolide antibiotic, roxithromycin suppresses IFN-gamma-mediated immunological functions of cultured normal human keratinocytes. Wakita H; Tokura Y; Furukawa F; Takigawa M Biol Pharm Bull; 1996 Feb; 19(2):224-7. PubMed ID: 8850311 [TBL] [Abstract][Full Text] [Related]
38. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. Zahradka P; Werner JP; Buhay S; Litchie B; Helwer G; Thomas S J Mol Cell Cardiol; 2002 Dec; 34(12):1609-21. PubMed ID: 12505059 [TBL] [Abstract][Full Text] [Related]
39. Roxithromycin treatment inhibits TGF-β1-induced activation of ERK and AKT and down-regulation of caveolin-1 in rat airway smooth muscle cells. Dai Y; Li F; Wu L; Wang R; Li P; Yan S; Xu H; Xia M; Bai C Respir Res; 2014 Aug; 15(1):96. PubMed ID: 25109503 [TBL] [Abstract][Full Text] [Related]
40. Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro. Asano K; Kamakazu K; Hisamitsu T; Suzaki H Int Immunopharmacol; 2001 Oct; 1(11):1913-21. PubMed ID: 11606023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]